Operating Lease, Right-of-Use Asset of Summit Therapeutics Inc. from 31 Jan 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Summit Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Jan 2018 to 30 Sep 2025.
  • Summit Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $5,420,000, a 32% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Summit Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,420,000 -$2,556,000 -32% 30 Sep 2025 10-Q 20 Oct 2025 2025 Q3
Q2 2025 $5,552,000 -$3,164,000 -36% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $6,351,000 -$3,022,000 -32% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $7,144,000 +$1,285,000 +22% 31 Dec 2024 10-Q 20 Oct 2025 2025 Q3
Q3 2024 $7,976,000 +$1,573,000 +25% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $8,716,000 +$1,720,000 +25% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $9,373,000 +$5,445,000 +139% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $5,859,000 +$1,684,000 +40% 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q3 2023 $6,403,000 +$2,173,000 +51% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $6,996,000 +$4,979,000 +247% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $3,928,000 +$1,496,000 +62% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $4,175,000 +$1,385,000 +50% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $4,230,000 +$2,346,000 +125% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $2,017,000 -$195,000 -8.8% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $2,432,000 +$945,000 +64% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $2,790,000 +$2,236,000 +404% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $1,884,000 +$1,256,000 +200% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $2,212,000 +$1,533,000 +226% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $1,487,000 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $554,000 -$467,000 -46% 31 Dec 2020 10-K/A 21 Dec 2022 2021 FY
Q3 2020 $628,000 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $679,000 30 Jun 2020 8-K 29 Sep 2020 2020 Q2
Q4 2019 $1,021,000 -$351,000 -26% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $1,372,000 -$605,000 -31% 31 Jan 2019 8-K 29 Sep 2020 2020 Q2
Q4 2017 $1,977,000 31 Jan 2018 8-K 29 Sep 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.